Medicare now funds home sleep studies for children aged 3–17

What just happened

From 1 July 2026, two new Medicare Benefits Schedule items allow children and adolescents to undergo home-based sleep studies for suspected sleep-disordered breathing — without requiring an overnight stay in a sleep laboratory.

The new items cover Level 2 polysomnography for medically uncomplicated young people aged 3–11 and adolescents aged 12–17. For eligible patients, home-based testing offers a less disruptive pathway: no overnight absence, no unfamiliar clinical environment, and in many cases faster access given the wait times for paediatric sleep laboratories in most Australian cities.

The change reflects a broader shift in sleep medicine: home-based testing is well established in adults with low clinical complexity, and the evidence base for extending it to young people has been accumulating. These MBS items represent the formal funding of that extension.

Both-and

What the new pathway covers — and what it doesn’t

The clinical qualifier is “medically uncomplicated.” The new items apply to children and adolescents being investigated for sleep-disordered breathing who do not require professional supervision overnight. This is a meaningful restriction.

Children with significant obesity, neurological conditions, congenital cardiac or craniofacial abnormalities, or neuromuscular disease are likely to fall outside it. Down syndrome, for example — where sleep-disordered breathing is highly prevalent — typically involves complexity that warrants laboratory-based polysomnography with overnight clinical oversight. For those children, the laboratory pathway remains the standard, and the new items don’t change that.

For families of children who are otherwise healthy, snoring loudly or showing signs of sleep-disordered breathing without complex comorbidities, the home pathway now provides a Medicare-funded option.

The referral structure for GPs has changed

The referral pathway is structured differently from the adult home sleep study pathway. For adults with suspected obstructive sleep apnoea, GPs can refer directly for home sleep studies under specific MBS items. For children, the new items work differently. GPs refer the child to a qualified sleep medicine practitioner, who performs a clinical assessment and then decides whether a home study is appropriate. The specialist decides the study type; the GP initiates the referral.

This distinction matters practically. A referral letter to a sleep laboratory requesting a home study for a child may not be processed the same way as a referral to a sleep medicine specialist for assessment and study planning. Understanding the structure — referral to a specialist, not direct-to-laboratory — is the operational detail GPs need to apply the new pathway correctly.

The underlying clinical question: who needs a sleep study?

Sleep-disordered breathing in children spans a spectrum: from primary snoring — loud but without apnoea, oxygen desaturation, or arousal — through upper airway resistance syndrome to frank obstructive sleep apnoea. The distinction matters because clinical management differs significantly along that spectrum.

The presenting complaint is usually a parent reporting snoring, mouth breathing, or restless sleep. The clinical assessment begins with history: witnessed apnoeas, snoring frequency and volume, daytime behaviour. Obstructive sleep apnoea in children has a different symptom profile from adults — daytime sleepiness is less prominent; inattention, hyperactivity, and irritability (often attributed to ADHD or behavioural causes) are recognised consequences of disrupted overnight breathing in paediatric patients.

For children in whom the clinical picture is clear — particularly adenotonsillar hypertrophy with classic symptoms — some ENT surgeons operate without formal polysomnography. But for cases where the diagnosis is uncertain or where risk factors complicate the picture, a sleep study provides the objective data that guides decision-making.

The new home study pathway is most useful for children where there is genuine diagnostic uncertainty but no clinical complexity requiring inpatient monitoring.

Wait times and the practical question

In most Australian cities, wait times for paediatric sleep laboratory studies are significant — commonly six to eighteen months at public hospitals. For families accessing private sleep medicine, the wait is shorter but the cost is higher. The addition of home-based options has the potential to decompress laboratory capacity by reserving it for complex cases that genuinely require overnight supervision.

Whether that decompression materialises depends on uptake and on the availability of accredited home sleep study services for children in each city. The items are new; the referral patterns will develop over the coming months.

What parents are usually asking

The question parents most often bring is whether their child’s snoring is a problem. The answer depends on features beyond the snoring itself: daytime consequences (sleepiness, behaviour, concentration), witnessed pauses in breathing, mouth breathing during waking hours, and growth trajectory. The Sleep Health Foundation has clear parent resources on recognising the features that warrant investigation.

Snoring without any of those associated features usually warrants watchful waiting and a GP review rather than immediate investigation. The presence of any associated features — particularly witnessed apnoea or significant daytime behavioural effects — warrants a GP review and potentially onward referral.

My two cents

For GPs with children presenting with suspected sleep-disordered breathing: the new Medicare pathway runs through a sleep medicine specialist, not direct to a laboratory. Refer for specialist assessment; the specialist determines study type. If you were previously referring children directly to sleep laboratories for home studies, the new items provide Medicare funding but require the specialist assessment step.

For parents: if your child snores loudly and shows any daytime signs — trouble concentrating, unusual hyperactivity, excessive tiredness for their age — it is worth raising with your GP. The new MBS items mean that for eligible children, a home sleep study is now funded. Whether your child is a candidate is a decision a sleep specialist makes after assessing them.

The pathway is straightforward: GP referral to a sleep medicine specialist, specialist assesses, appropriate study arranged.

Verdict: yes — a practical change to how children access sleep assessment in Australia, with a specific referral structure GPs and paediatricians need to know.

---

Sources cited

1. Medicare backs home sleep studies for kids. Medical Republic, 13 August 2026. https://www.medicalrepublic.com.au/medicare-backs-home-sleep-studies-for-kids/128152
2. Sleep Health Foundation — children’s sleep resources. https://www.sleephealthfoundation.org.au/
3. MBS Online — Medicare Benefits Schedule. https://www.mbsonline.gov.au/